• EPO for stroke therapy - Is there a future for further clinical development?
  EPO for stroke therapy - Is there a future for further clinical development?

  Exp Transl Stroke Med. 2010 May 12;2(1):10.
  PubMed
• Two pore domain potassium channels in cerebral ischemia: a focus on K2P9.1 (TASK...
  Two pore domain potassium channels in cerebral ischemia: a focus on K2P9.1 (TASK3, KCNK9).

  Exp Transl Stroke Med. 2010 Jul 20 ;2(1):14.
  PubMed
• COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, d...
  COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke.

  Exp Transl Stroke Med. 2010 Feb 15 ;2(1):5.
  PubMed
• The PGE2 EP2 receptor and its selective activation are beneficial against ischem...
  The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke.

  Exp Transl Stroke Med. 2010 Jul 8 ;2(1):12.
  PubMed
• Related Citations for PubMed (Select 20298535) (96)
  PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on